NRAS and acute myeloid leukemia: However, the role of miR-708 in melanoma and acute myeloid leukemia (AML) has yet to be characterized, and whether the expression of NRAS, one of the most important oncogenes in these cancers, is targeted by miR-708 remains unknown.